Related Experiment Video
Updated: Aug 9, 2026

Membrane Potential Dye Imaging of Ventromedial Hypothalamus Neurons From Adult Mice to Study Glucose Sensing
Published on: November 27, 2013
Alterations in insulin and glucagon secretion by monosodium glutamate lesions of the hypothalamic arcuate nucleus
Abstract:
This study was performed to determine the effects of monosodium glutamate (MSG) induced lesions of the hypothalamic arcuate nucleus (ARC) on glucose tolerance and insulin and glucagon secretion in male golden hamsters. Eight day old hamsters were given a single s.c. injection of 5.8 mg/g BW MSG or hypertonic saline (controls). Studies were initiated when the hamsters were 3 months of age. At this age there were no body weight differences. Glucose (180 mg/100 g BW) was administered via stomach tube to 18 control and 18 MSG-treated hamsters. Animals were anesthetized with ether and a single blood sample from the portal vein was taken either before or at 30 or 60 min after glucose administration (n = 6/group). Glucose concentrations were similar in both groups at all time periods. Insulin concentrations in the MSG group were significantly (P less than 0.05) elevated in MSG-treated hamsters compared to controls at the 60 min time point. Glucose suppressed glucagon (P less than 0.05) in control but not in MSG-treated hamsters. The MSG group had significantly more glucagon (P less than 0.05) in portal vein blood at 30 min after glucose administration than did the control hamsters. Molar insulin/glucagon ratios did not differ between the 2 groups which likely accounts for the lack of differences in blood glucose levels. These results suggest a role for the ARC in regulating pancreatic function.
Related Concept Videos
Insulin Secretory Vesicles
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...
Regulation of Food Intake
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are co-secreted in...
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
Hypoglycemia and Glucagon

